NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$22.4

Market cap

$504.82M

P/E Ratio

58.95

Dividend/share

$0.6

EPS

$0.38

Enterprise value

$580.31M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 72

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The gross margin has grown by 2.5% year-on-year
The stock's price to earnings (P/E) is 110% more than its 5-year quarterly average of 28.1 and 93% more than its last 4 quarters average of 30.5
The EPS has dropped by 63% year-on-year and by 24% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://nrchealth.com

Key stats

What are the main financial stats of NRC

NRC stock price

How has the National Research stock price performed over time
Intraday
0.27%
1 week
9.06%
1 month
14.34%
1 year
35.43%
YTD
19.34%
QTD
3.85%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$138.64M
Gross profit
$85.68M
Operating income
$19.56M
Net income
$9.04M
Gross margin
61.8%
Net margin
6.5%
NRC's net income has shrunk by 63% YoY and by 22% QoQ
National Research's net margin has shrunk by 62% YoY and by 23% QoQ
NRC's operating income is down by 44% YoY and by 13% QoQ
National Research's operating margin has decreased by 43% YoY and by 14% QoQ

Price vs fundamentals

How does NRC's price correlate with its fundamentals

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
58.95
P/B
37.76
P/S
3.52
EV/EBIT
29.58
EV/EBITDA
20.82
EV/Sales
4.19
The stock's price to earnings (P/E) is 110% more than its 5-year quarterly average of 28.1 and 93% more than its last 4 quarters average of 30.5
The EPS has dropped by 63% year-on-year and by 24% since the previous quarter
NRC's price to book (P/B) is 123% more than its 5-year quarterly average of 16.9 and 55% more than its last 4 quarters average of 24.4
National Research's equity has shrunk by 55% YoY and by 3.5% QoQ
The P/S is 35% higher than the last 4 quarters average of 2.6 but 31% lower than the 5-year quarterly average of 5.1

Efficiency

How efficient is National Research business performance
The return on assets has dropped by 65% year-on-year and by 22% since the previous quarter
NRC's return on invested capital has dropped by 61% year-on-year and by 16% since the previous quarter
The return on sales has declined by 43% year-on-year and by 14% since the previous quarter
NRC's return on equity is down by 20% year-on-year and by 2.1% since the previous quarter

Dividends

What is NRC's dividend history
Dividend details
DPS
$0.6
Dividend yield
2.68%
Payout ratio
157.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did National Research financials performed over time
NRC's total assets is 11% greater than its total liabilities
The quick ratio has declined by 17% since the previous quarter and by 5% year-on-year
National Research's total liabilities has increased by 15% YoY
NRC's debt to equity has soared by 163% YoY and by 2.3% QoQ
National Research's equity has shrunk by 55% YoY and by 3.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.